Brokerage firms Nuvama, CLSA, and Macquarie have highlighted strong growth prospects for TCS, Bajaj Finance, and IRCTC, ...

TCS shares surge 6% post Q3 results, brokerages optimistic, net profit up 5.5%, dividend declared, target prices revised.

The retail sector delivered a mixed performance during the festive season, with select pockets emerging as bright spots, ...

Dr. Reddy’s Laboratories shares rose 4% after Nuvama upgraded its rating to 'buy,' citing proactive strategies to mitigate ...

Nuvama assigned a target price of Rs 1,553 per share on Dr. Reddy's stock, implying an upside of 14.8% from the previous ...

Buoyed by signs of early demand revival, the management of TCS guided for stronger growth in CY25 and FY26 versus that seen ...

The surge in Dr. Reddy's share followed an upgrade by domestic brokerage Nuvama, which raised its rating on the stock to 'Buy ...

Avenue Supermarts, operator of DMart, is expected to report an 18% YoY revenue growth to Rs 16,016 crore for Q3FY25, with net ...

Tata Consultancy Services have 'Buy' ratings from brokers despite mixed Q3 FY25 results; discover insights on stock ...

Dr Reddy’s share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to ’Buy’ with a target of ...

India's economy is experiencing subdued demand and slower growth across sectors due to weak household incomes and sluggish ...

Nomura, on January 6, upgraded SBI Card share to ‘Buy’ from ‘Reduce’ on rising share of top metro cities in its new card ...